IPHA rejects NCPE’s charge of ‘illegality’ over ‘predatory’ medicines pricing

The Irish Pharmaceutical Healthcare Association (IPHA), which represents pharmaceutical innovators, has rejected a claim made today [Monday] by the National Centre for Pharmoeconomics (NCPE) that medicines pricing is ‘predatory’, saying that it amounts to a charge of illegality against the industry.

The NCPE is the body that advises the Health Service Executive (HSE) on the cost-effectiveness of medicines.